These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23740390)

  • 41. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier.
    Prades R; Oller-Salvia B; Schwarzmaier SM; Selva J; Moros M; Balbi M; Grazú V; de La Fuente JM; Egea G; Plesnila N; Teixidó M; Giralt E
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3967-72. PubMed ID: 25650865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB.
    Di L; Kerns EH; Bezar IF; Petusky SL; Huang Y
    J Pharm Sci; 2009 Jun; 98(6):1980-91. PubMed ID: 18837012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new descriptor via bio-mimetic chromatography and modeling for the blood brain barrier (Part II).
    Kouskoura MG; Piteni AI; Markopoulou CK
    J Pharm Biomed Anal; 2019 Feb; 164():808-817. PubMed ID: 29884296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Models for predicting blood-brain barrier permeation.
    Nielsen PA; Andersson O; Hansen SH; Simonsen KB; Andersson G
    Drug Discov Today; 2011 Jun; 16(11-12):472-5. PubMed ID: 21513815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mathematical model for prediction of drug molecule diffusion across the blood-brain barrier.
    Burns J; Weaver DF
    Can J Neurol Sci; 2004 Nov; 31(4):520-7. PubMed ID: 15595260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
    Vastag M; Keseru GM
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods.
    Wang Z; Yang H; Wu Z; Wang T; Li W; Tang Y; Liu G
    ChemMedChem; 2018 Oct; 13(20):2189-2201. PubMed ID: 30110511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of blood-brain barrier permeability using machine learning approaches based on various molecular representation.
    Liang L; Liu Z; Yang X; Zhang Y; Liu H; Chen Y
    Mol Inform; 2024 Sep; 43(9):e202300327. PubMed ID: 38864837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches.
    Fan Y; Unwalla R; Denny RA; Di L; Kerns EH; Diller DJ; Humblet C
    J Chem Inf Model; 2010 Jun; 50(6):1123-33. PubMed ID: 20578728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Qualitative and quantitative structure-activity relationship modelling for predicting blood-brain barrier permeability of structurally diverse chemicals.
    Gupta S; Basant N; Singh KP
    SAR QSAR Environ Res; 2015; 26(2):95-124. PubMed ID: 25629764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brainpeps: the blood-brain barrier peptide database.
    Van Dorpe S; Bronselaer A; Nielandt J; Stalmans S; Wynendaele E; Audenaert K; Van De Wiele C; Burvenich C; Peremans K; Hsuchou H; De Tré G; De Spiegeleer B
    Brain Struct Funct; 2012 Jul; 217(3):687-718. PubMed ID: 22205159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
    Bicker J; Alves G; Fortuna A; Falcão A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase.
    Danjo S; Ishihara Y; Watanabe M; Nakamura Y; Itoh K
    Brain Res; 2013 Sep; 1530():44-53. PubMed ID: 23831997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The grasshopper: a novel model for assessing vertebrate brain uptake.
    Andersson O; Hansen SH; Hellman K; Olsen LR; Andersson G; Badolo L; Svenstrup N; Nielsen PA
    J Pharmacol Exp Ther; 2013 Aug; 346(2):211-8. PubMed ID: 23671124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states.
    Deo AK; Theil FP; Nicolas JM
    Mol Pharm; 2013 May; 10(5):1581-95. PubMed ID: 23256608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breaking the Barriers: Machine-Learning-Based c-RASAR Approach for Accurate Blood-Brain Barrier Permeability Prediction.
    Kumar V; Banerjee A; Roy K
    J Chem Inf Model; 2024 May; 64(10):4298-4309. PubMed ID: 38700741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.